omniture

China Health Resource Announces Participation in DAR General Session

2011-10-04 18:04 1252

SICHUAN, China, October 4, 2011 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), a producer and supplier of Traditional Chinese Medicine (TCM) products, announced today that it will participate in the 2011 session of the Dahurian Angelica Root Association of Suining City (DAR Association) and in the General Session where CHRI's Chairman and CEO, Mr. Jiayin Wang is seeking re-election. The DAR Association is a cooperative of over 100,000 farmers of Dahurian Angelica Root (DAR) that seek to pool their collective resources to provide economic and productivity benefits to its farmer members. In attendance to the DAR Association Session this year is Deputy General Mayor Yun Liu and Jiazheng Hu, Deputy Mayor and head of medical and health division along with other government and industrial leaders.

One important agenda of this year's DAR Association session is the election of the new chairman for the DAR Association. Mr. Wang is the presiding Chairman of the DAR Association. There are totally three candidates seeking for this year's Chairman position.

As the present Chairman of Suining DAR Association Mr. Wang, Jiayin said, "In recent years and through the collective unification of the members of the DAR Association, the support of local government and academia, Dahurian Angelica Root (DAR) has become one of the famous authentic Sichuan TCM herbs in China and abroad obtains a higher recognition and a relatively high quality compliance rate; and its market value has been better reflected with a relatively reasonable market price range. The DAR Association with the united help of its member's and through hard-work and mutual co-operation has been inseparable principles for this success."

"The use of General Agricultural Process (GAP) as DAR's quality standard is a most important factors in increasing DAR market acceptance with a standard of quality. Only with such standard can China's DAR be recognized in pharmaceutical usage and other high quality applications in expand worldwide," emphasized Mr. Wang.

Speaking on behalf of CHRI, Mr. Weihai liu, CFO said: "Through the civil efforts of the DAR Association and the support from local government, CHRI has benefitted from the accomplishment of an otherwise insurmountable task of managing close to one hundred small farm villages to operate efficiently and cost effectively and with a scientific measure of quality. We consider the existence and future role of DAR Association of great importance as it has in the past. Through the union of the farmers, CHRI can efficiently and cost effectively produce and process large quantities of DAR for sales."

Mr. Liu further said: "CHRI President Mr. Jiayin Wang is the best suited person to continue to lead the DAR Association. His name recognition at all level of government and in the industry as well as care for the well being of the farmers is well recognized. He was a 12 consecutive times award recipient for the prestigious federal level award, and 2006 China's 500 great entrepreneurs awarded by the President of PRC. I cannot think of any other person with the reputation and devotion of Jiayin Wang to head this important position for the DAR Association."

Mr. Wang in his statement for seeking re-election as Chairman of the DAR Association said: "I, as a native Suining citizen, I am confident that I can continue serve as the new term chairman of DAR association. And I hope all the DAR Association farmer members and companies that work with the DAR Association can continue to work together to further enhance the reputation of Sichuan DAR and promote enforcement of quality standards for DAR worldwide, to ensure acceptance of pharmaceutical grade and high quality grade China's TCM herbs and authentic TCM. I will continue to enforce and promote the quality standard through all DAR members and create more awareness of the need for quality standards. I will further fight any corrupt practices that can undermine the quality standards DAR Association has work hard to establish," emphasized Chairman Wang as his re-election pledge.

About CHRI

China Health Resource, Inc. engages in the development, manufacturing, processing, marketing and sale of Dahurian Angelica Root (DAR) and is only the provider of GAP quality product in the People's Republic of China under the registered Trademark Chuan Baizhi™. DAR, which is also known as "Bai Zhi" in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics and food, as well as used in TCM for the treatment of pain, swelling and pustule. The Company's DAR-related products include the Bailing Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant Bag, all of which are sold through regional distributors. The Company was founded in 2001 and is based in Suining, Sichuan Province.

Certain statements in this document regarding financial matters, other than historical facts, and statements of our expectations, intentions, plans and beliefs, constitute "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to certain events, risks and uncertainties that may be outside our control. The words "believe", "expect", "anticipate", "optimistic", "intend", "will", and similar expressions identify forward-looking statements. The company intends that such proclamations about future expectations, including future revenues and earnings, future business expansion plans, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. These and other risks and uncertainties related to our business are described in greater detail in our filings with the Commission. The foregoing information should be read in conjunction with these filings. We disclaim any intention or obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.

Source: China Health Resource, Inc.
Related Stocks:
OTC:CHRI
collection